News
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...
1don MSN
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
Bloomberg on MSN4d
Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&ANovartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...
Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...
Some GOP lawmakers and pro-trade lobbyists are quietly seeking to rein in the most extreme elements of the Trump ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
MSCI's global equity index edged up on Monday and longer U.S. Treasury yields ticked higher as the latest U.S. tariff threats ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent ...
7hon MSN
Verizon Communications helped lead the way and rose 4.8%. The telecom reported a stronger profit for the latest quarter than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results